These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 2759035

  • 21. Processing of chromogranin A in the parathyroid: generation of parastatin-related peptides.
    Fasciotto BH, Denny JC, Greeley GH, Cohn DV.
    Peptides; 2000 Sep; 21(9):1389-401. PubMed ID: 11072127
    [Abstract] [Full Text] [Related]

  • 22. The effects of phorbol myristate acetate on the intracellular degradation of bovine parathyroid hormone.
    Tanguay KE, Mortimer ST, Wood PH, Hanley DA.
    Endocrinology; 1991 Apr; 128(4):1863-8. PubMed ID: 2004606
    [Abstract] [Full Text] [Related]

  • 23. Current status on chromogranin A and pancreastatin.
    Robberecht P, Lingier P, Woussen-Colle MC.
    Acta Gastroenterol Belg; 1993 Apr; 56(3-4):261-3. PubMed ID: 8266767
    [Abstract] [Full Text] [Related]

  • 24. Pancreastatin inhibits insulin secretion and exocrine pancreatic secretion in the pig.
    Ahrén B, Pierzynowski SG, Weström B, Karlsson B.
    Diabetes Res; 1990 Jun; 14(2):93-6. PubMed ID: 2134219
    [Abstract] [Full Text] [Related]

  • 25. A comparison of the effects of concanavalin-A and tetradecanoylphorbol acetate on the modulation of parathyroid function by extracellular calcium and neomycin in dispersed bovine parathyroid cells.
    Brown EM, Butters R, Katz C, Kifor O, Fuleihan GE.
    Endocrinology; 1992 Jun; 130(6):3143-51. PubMed ID: 1317777
    [Abstract] [Full Text] [Related]

  • 26. Pancreastatin secretion by pituitary adenomas and regulation of chromogranin B mRNA expression.
    Jin L, Scheithauer BW, Young WF, Davis DH, Klee GG, Lloyd RV.
    Am J Pathol; 1996 Jun; 148(6):2057-66. PubMed ID: 8669489
    [Abstract] [Full Text] [Related]

  • 27. The primary structure of human chromogranin A and pancreastatin.
    Konecki DS, Benedum UM, Gerdes HH, Huttner WB.
    J Biol Chem; 1987 Dec 15; 262(35):17026-30. PubMed ID: 2445752
    [Abstract] [Full Text] [Related]

  • 28. Individual parathyroid cells exhibit cyclic secretion of parathyroid hormone and chromogranin-A (as measured by a novel sequential hemolytic plaque assay).
    Ritchie CK, Cohn DV, Maercklein PB, Fitzpatrick LA.
    Endocrinology; 1992 Dec 15; 131(6):2638-42. PubMed ID: 1446605
    [Abstract] [Full Text] [Related]

  • 29. Isolation and primary structure of tumor-derived peptides related to human pancreastatin and chromogranin A.
    Schmidt WE, Siegel EG, Kratzin H, Creutzfeldt W.
    Proc Natl Acad Sci U S A; 1988 Nov 15; 85(21):8231-5. PubMed ID: 3186720
    [Abstract] [Full Text] [Related]

  • 30. Porcine pancreastatin has no effect on endocrine secretion from the pig pancreas.
    Holst JJ, Ostenson CG, Harling H, Messell T.
    Diabetologia; 1990 Jul 15; 33(7):403-6. PubMed ID: 1976102
    [Abstract] [Full Text] [Related]

  • 31. Effects of protein kinase C activation on inositol phosphate generation and intracellular Ca2+ mobilization in bovine parathyroid cells.
    Shoback DM, Chen TH.
    Endocrinology; 1990 Jul 15; 127(1):141-8. PubMed ID: 2361470
    [Abstract] [Full Text] [Related]

  • 32. Effects of insulin on the synthesis, intracellular degradation, and secretion of parathormone.
    Hinton DA, MacGregor RR.
    Endocrinology; 1991 Jan 15; 128(1):488-95. PubMed ID: 1986940
    [Abstract] [Full Text] [Related]

  • 33. Effects of pancreastatin and chromogranin A on insulin release stimulated by various insulinotropic agents.
    Ishizuka J, Tatemoto K, Cohn DV, Thompson JC, Greeley GH.
    Regul Pept; 1991 Jun 11; 34(1):25-32. PubMed ID: 1857778
    [Abstract] [Full Text] [Related]

  • 34. Pancreastatin: molecular and immunocytochemical characterization of a novel peptide in porcine and human tissues.
    Schmidt WE, Siegel EG, Lamberts R, Gallwitz B, Creutzfeldt W.
    Endocrinology; 1988 Sep 11; 123(3):1395-404. PubMed ID: 3042370
    [Abstract] [Full Text] [Related]

  • 35. The putative role of secretory protein-I/chromogranin A as a precursor for regulatory hormones.
    Cohn DV, Fasciotto BH, Gorr SU, Parkins F, Shioi J, Levine MA, Greeley GH.
    Prog Clin Biol Res; 1990 Sep 11; 332():51-66. PubMed ID: 2184441
    [No Abstract] [Full Text] [Related]

  • 36. Pancreastatin inhibits insulin secretion in RINm5F cells through obstruction of G-protein mediated, calcium-directed exocytosis.
    Hertelendy ZI, Patel DG, Knittel JJ.
    Cell Calcium; 1996 Feb 11; 19(2):125-32. PubMed ID: 8689670
    [Abstract] [Full Text] [Related]

  • 37. Pancreastatin--a novel regulatory peptide?
    Schmidt WE, Creutzfeldt W.
    Acta Oncol; 1991 Feb 11; 30(4):441-9. PubMed ID: 1854501
    [Abstract] [Full Text] [Related]

  • 38. Determination of residues in chromogranin A-(16-40) required for inhibition of parathyroid hormone secretion.
    Angeletti RH, Mints L, Aber C, Russell J.
    Endocrinology; 1996 Jul 11; 137(7):2918-22. PubMed ID: 8770914
    [Abstract] [Full Text] [Related]

  • 39. Characterization of immunoreactive pancreastatin in porcine tissues.
    Børglum Jensen TD, Holst JJ, Fahrenkrug J.
    Scand J Clin Lab Invest; 1991 Dec 11; 51(8):681-91. PubMed ID: 1806983
    [Abstract] [Full Text] [Related]

  • 40. [Effect of pancreastatin on insulin secretion and the exocrine pancreas in rats].
    von Schönfeld J, Müller MK, Neisius I, Geling M, Rünzi M, Goebell H.
    Z Gastroenterol; 1991 Oct 11; 29(10):523-6. PubMed ID: 1781189
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.